XML 82 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (7,902,000) $ (10,063,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 1,058,000 1,136,000
Issuance of common stock for bonus 870,000
Stock based payments for professional services rendered 190,000
Stock based payments 4,000
(Loss)/gain on equity method investment 5,000 (7,000)
Loss (gain) on investments 303,000 572,000
Change in ROU assets 330,000 369,000
Change in inventory obsolescence (21,000)
Accrued interest on notes payable 1,884,000
Loss (Gain) on sale of assets 250,000 (165,000)
Impairment of intangibles 600,000
Provision for loan losses 235,000 815,000
Decrease (increase) in assets:    
Accounts receivable 380,000 1,679,000
Inventory (80,000) (753,000)
Assets held for sale (38,000)
Prepaid expenses and other current assets 241,000 504,000
Other assets (802,000) (42,000)
Increase (decrease) in liabilities:    
Accounts payable (287,000) (224,000)
Accrued expenses (26,000) (529,000)
ROU liabilities (313,000) (339,000)
Other liabilities 3,549,000 1,473,000
Net cash provided (used) by operating activities 430,000 (5,574,000)
Cash flows from investing activities:    
Purchase of property, plant and equipment (144,000) (29,000)
Sale of real estate 9,500,000
Purchase of marketable securities (1,000,000)
Purchase of investment (379,000)
Disposal of property, plant and equipment 5,140,000
Sale of investment, related party 1,500,000
Sale of marketable securities 116,000
Payments received on notes receivable 163,000 4,044,000
Net cash provided by investing activities 10,135,000 8,776,000
Cash flows from financing activities:    
Payments of long-term debt (9,443,000) (1,269,000)
Borrowings of long-term debt 109,000 2,171,000
Payments on margin loan (3,178,000)
Net cash (used) provided by financing activities (12,512,000) 902,000
Net increase (decrease) in cash (1,947,000) 4,104,000
Cash and cash equivalents at beginning of period 11,431,000 6,615,000
Cash and cash equivalents at end of period $ 9,484,000 $ 10,719,000